# Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension

> **NCT01413048** · PHASE3 · UNKNOWN · sponsor: **Ahn-Gook Pharmaceuticals Co.,Ltd** · enrollment: 260 (estimated)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** Carvedilol 25mg
- **DRUG:** AGSCT101 12.5mg

## Key facts

- **NCT ID:** NCT01413048
- **Lead sponsor:** Ahn-Gook Pharmaceuticals Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2012-03
- **Final completion:** 2012-09
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2011-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01413048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01413048, "Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01413048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*